Showing results (121-130 of 361) with videos related to

Sort By:
Pageof 37
Annals of Vascular Surgery|May 20, 2026
Sodium Glucose Cotransporter-2 inhibitors are not associated with amputation after lower extremity revascularization in patients with diabetesUma D Alappan, Ashwin K Chetty, Warren Carter, et al.
Hospital Practice (1995)|November 3, 2015
Hyperglycemia grand rounds: descriptive findings of outcomes from a continuing education intervention to improve glycemic control and prevent hypoglycemia in the hospital settingEtie S Moghissi, Silvio E Inzucchi, Katherine V Mann, et al.
Diabetes Care|June 29, 2005
Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care ProjectSilvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, et al.
Diabetes Research and Clinical Practice|May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trialSilvio E Inzucchi, Christoph Wanner, David Fitchett, et al.
Current Medical Research and Opinion|May 27, 2017
A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapyR Ravi Shankar, Silvio E Inzucchi, Victoria Scarabello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2024
How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trialChristoph Wanner, Masaomi Nangaku, Bettina J Kraus, et al.
Diabetes & Vascular Disease Research|January 10, 2012
Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: results from the DIAD studySuman Tandon, Frans J T Wackers, Silvio E Inzucchi, et al.
Archives of Internal Medicine|March 11, 2009
Glucose normalization and outcomes in patients with acute myocardial infarctionMikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, et al.
Cardiovascular Diabetology|November 27, 2020
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trialJoão Pedro Ferreira, Subodh Verma, David Fitchett, et al.
The Journal of Clinical Investigation|May 22, 2002
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetesRipudaman S Hundal, Kitt F Petersen, Adam B Mayerson, et al.
Pageof 37